Cancer
metastatic spread is life-threatening and caused by circulating
tumor cells (CTCs) that are very difficult to precisely capture in
vivo. Here we show that two aptamer rings targeting different CTC
biomarker epitopes conjugated on dendrimers capture CTCs with enhanced
precision even in the presence of 108 interfering cells,
or blood cells, and in mice or patient samples when compared with
their single aptamer counterparts. The aptamer-conjugate inhibited
in vivo metastasis and demonstrated enhanced biostability by resisting
biodegradation caused by the endogenous nucleases. The capture arms
of the aptamer conjugates could simultaneously and specifically seize
two biomarkers (EpCAM and Her2). The double seizure resulted in significant
cell-cycle arrest, apoptosis, and growth inhibition of the captured
CTCs. The aptamer-conjugate highly penetrated and accumulated in mouse
tumors. This study provides the first conceptual evidence that two
aptamer rings, inexpensive but bioequivalent to their antibodies,
can be biocompatibly conjugated to specifically capture and down-regulate
CTCs in vivo with the enhanced biostability.